Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trial.
Ono M, Tomaniak M, Koenig W, Khamis R, de Silva R, Chichareon P, Kawashima H, Hara H, Gao C, Wang R, Huber K, Vrolix M, Jasionowicz P, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Steg PG, Windecker S, Onuma Y, Storey RF, Serruys PW.
Ono M, et al. Among authors: serruys pw.
Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):39-47. doi: 10.1093/ehjcvp/pvaa110.
Eur Heart J Cardiovasc Pharmacother. 2022.
PMID: 32956446
Clinical Trial.